|

Darlifarnib Clinical Trials

1 actively recruiting trial across 1 location

Also known as: KO-2806

Pipeline

Phase 1: 1

Top Sponsors

  • Kura Oncology, Inc.1

Indications

  • Solid Tumors With HRAS Alterations1
  • Non-Clear Cell Renal Cell Carcinoma (nccRCC)1
  • Clear Cell Renal Cell Carcinoma (ccRCC)1
  • Renal Cell Carcinoma (Kidney Cancer)1
  • Pancreatic Ductal Adenocarcinoma (PDAC)1

Phoenix, Arizona1 trial

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Mayo Clinic Comprehensive Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.